ArticleSchizophrenia research2026

Aripiprazole two-month long-acting injectable may increase time to readmission compared to aripiprazole one-month in patients with schizophrenia and schizoaffective disorder.

Sean T Lynch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.